219 related articles for article (PubMed ID: 37176869)
1. A Scoping Review of Genus
Melo MNO; Batista JVDC; Peñaloza EMC; Oliveira AP; Garrett R; Baumgartner S; Holandino C
Plants (Basel); 2023 Apr; 12(9):. PubMed ID: 37176869
[TBL] [Abstract][Full Text] [Related]
2. Exploring the resources of the genus Viscum for potential therapeutic applications.
Song C; Wei XY; Qiu ZD; Gong L; Chen ZY; Ma Y; Shen Y; Zhao YJ; Wang WH; Lai CJ; Yang B
J Ethnopharmacol; 2021 Sep; 277():114233. PubMed ID: 34044077
[TBL] [Abstract][Full Text] [Related]
3. [Lectins in Viscum:a progress review].
Li JQ; Yang B
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3551-3559. PubMed ID: 34402277
[TBL] [Abstract][Full Text] [Related]
4. Viscum album L. homogenizer-assisted and ultrasound-assisted extracts as potential sources of bioactive compounds.
Stefanucci A; Zengin G; Llorent-Martinez EJ; Dimmito MP; Della Valle A; Pieretti S; Ak G; Sinan KI; Mollica A
J Food Biochem; 2020 Sep; 44(9):e13377. PubMed ID: 32713043
[TBL] [Abstract][Full Text] [Related]
5. Phytochemical screening and effect of Viscum album L. on monoamine oxidase A and B activity and serotonin, dopamine and serotonin receptor 5-HTR1A levels in Galleria mellonealla (Lepidoptera).
Szurpnicka A; Wrońska AK; Bus K; Kozińska A; Jabłczyńska R; Szterk A; Lubelska K
J Ethnopharmacol; 2022 Nov; 298():115604. PubMed ID: 35944736
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
[TBL] [Abstract][Full Text] [Related]
7. Viscum articulatum Burm. f. aqueous extract exerts antiproliferative effect and induces cell cycle arrest and apoptosis in leukemia cells.
Mishra R; Sharma S; Sharma RS; Singh S; Sardesai MM; Sharma S; Mishra V
J Ethnopharmacol; 2018 Jun; 219():91-102. PubMed ID: 29555410
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of mistletoe in CNS-related neurological disorders and the chemical composition of Viscum species.
Szurpnicka A; Zjawiony JK; Szterk A
J Ethnopharmacol; 2019 Mar; 231():241-252. PubMed ID: 30458281
[TBL] [Abstract][Full Text] [Related]
9. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
[TBL] [Abstract][Full Text] [Related]
10. Comparative Assessment of Biological Activities of Mistletoes for Cosmetic Applications:
Choi SU; Kim ST; Han DG; Hwang YH; Lee KY; Kim DU; Cho KH; Park SY; Kim HC; Kim SB; Jang DJ
J Cosmet Sci; 2019; 70(5):235-245. PubMed ID: 31596226
[TBL] [Abstract][Full Text] [Related]
11. Phytochemical profile and therapeutic potential of Viscum album L.
Nazaruk J; Orlikowski P
Nat Prod Res; 2016; 30(4):373-85. PubMed ID: 25813519
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical Characterization of
García-García JD; Anguiano-Cabello JC; Arredondo-Valdés R; Candido Del Toro CA; Martínez-Hernández JL; Segura-Ceniceros EP; Govea-Salas M; González-Chávez ML; Ramos-González R; Esparza-González SC; Ascacio-Valdés JA; López-Badillo CM; Ilyina A
Plants (Basel); 2021 Jun; 10(7):. PubMed ID: 34206859
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
14. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
15.
Melo MNO; Ochioni AC; Zancan P; Oliveira AP; Grazi M; Garrett R; Holandino C; Baumgartner S
Front Pharmacol; 2022; 13():1027931. PubMed ID: 36386174
[No Abstract] [Full Text] [Related]
16. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
17. Phenolic compounds from
Melo MNO; Oliveira AP; Wiecikowski AF; Carvalho RS; Castro JL; de Oliveira FAG; Pereira HMG; da Veiga VF; Capella MMA; Rocha L; Holandino C
Saudi Pharm J; 2018 Mar; 26(3):311-322. PubMed ID: 29556122
[TBL] [Abstract][Full Text] [Related]
18. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
19. Morphology, geographic distribution, and host preferences are poor predictors of phylogenetic relatedness in the mistletoe genus Viscum L.
Maul K; Krug M; Nickrent DL; Müller KF; Quandt D; Wicke S
Mol Phylogenet Evol; 2019 Feb; 131():106-115. PubMed ID: 30399429
[TBL] [Abstract][Full Text] [Related]
20. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
